Related Experiment Video
Updated: May 12, 2026

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
Published on: October 28, 2022
Unraveling the toxicokinetics of the mycotoxins T-2 and HT-2 toxin in humans for developing a physiologically-based
Hannah P McKeon1, Joost Westerhout1, Marloes A A Schepens1
1National Institute for Public Health and the Environment (RIVM), Bilthoven, 3720 BA, the Netherlands.
Abstract:
T-2 toxin (T-2) and HT-2 toxin (HT-2) are trichothecene mycotoxins frequently detected in cereals. While exposure has primarily been evaluated using dietary assessment methods, human biomonitoring provides an alternative approach to assess internal exposure. This follow-up research aimed to further characterise the toxicokinetics of the mycotoxins T-2 and HT-2 and to subsequently develop a physiologically based kinetic (PBK) model, enabling prediction of urinary biomarker concentrations based on external exposure and vice versa. To this end, urine samples from 40 Norwegian adults were analysed for T-2 and its metabolites using targeted and suspect screening analytical approaches. Dietary exposure of these participants was estimated using 24-h weighed food records combined with Norwegian occurrence data. In parallel, toxicokinetic information on the mycotoxins was generated using in vitro liver microsome experiments and a literature review. Total HT-2 (HT-2 and its glucuronides) was detected in 97% of the 24-h urine voids, whereas total T-2 and T-2 triol were not detected. Suspect screening tentatively identified eight mono- and di-hydroxylated metabolites of T-2 and HT-2. In vitro, 98% of T-2 was metabolised within 2 h, with HT-2 accounting for 97% of the metabolites. Following a 2 h incubation with HT-2, 73% of the added HT-2 remained unchanged, and a large fraction was unidentified compounds (26%). Parametrisation of the PBK model was supported by data from public literature. This study advances the understanding of the human toxicokinetics of T-2 and HT-2, and demonstrates the utility of PBK modelling to link external and internal exposure. The identification of multiple hydroxylated urinary metabolites suggests that HT-2 alone does not fully represent internal exposure. This research provides direction for future metabolism studies which are needed to support further development of a robust PBK model for T-2 and HT-2.
Related Concept Videos
Toxicokinetics: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Toxicity Testing in Animals
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

